Antibody discovery platform for pharma partners (AI-driven)
Sector: health
Conviction from: NASDAQ
52-week range: 2.7515.02
3 tracked filer(s) hold this · 2 opened, 0 added, 1 trimmed in 30-SEP-2026
Aggregate 13FScore 56 — mean of 3 scored holder(s) · buyers (new/add) avg 54. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
| Filed | Insider | Role | Shares | Value | |
|---|
| 2026-11-12 | Thermopylae Holdings Ltd. | 10%-owner | 60,565 | $698,920 | Form 4 |
| 2026-08-24 | Hayden Michael R | director | 53,613 | $570,442 | Form 4 |
| 2026-08-14 | Booth Andrew (cluster of 2) | officer | 37,200 | $383,904 | Form 4 |
| 2026-08-14 | Hayden Michael R (cluster of 2) | director | 46,387 | $481,033 | Form 4 |
| 2026-02-27 | Thermopylae Holdings Ltd. | 10%-owner | 177,457 | $580,284 | Form 4 |
| Report | Date | Stance |
|---|
| #124 — State of the Themes: June 2026 | 2026-06-01 | WATCH |